1 - Long GH, Cooper AJM, Wareham NJ, Griffin SJ, Simmons RK. Healthy behavior change and cardiovascular outcomes in newly diagnosed type 2 diabetic patients: a cohort analysis of the ADDITION-Cambridge study. Diabetes Care. 2014;37(6):1712–1720. doi:10.2337/dc13-2180. Disponível em: https://diabetesjournals.org/care/article/37/6/1712/29998/Healthy-Behavior-Change-and-Cardiovascular​:contentReference[oaicite:0]{index=0}

3 - Newcastle Magnetic Resonance Centre. Reversing Type 2 Diabetes and ongoing remission. 2024. Disponível em: https://www.ncl.ac.uk/magres/research/diabetes/reversal/​:contentReference[oaicite:1]{index=1}

‍4 - Ravichandran S, Rajendran R, Balasubramanian R. Role of chromium supplementation in Indians with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2003;62(1):41–47. doi:10.1016/S0168-8227(03)00158-0. Disponível em: https://pubmed.ncbi.nlm.nih.gov/12550067/​:contentReference[oaicite:2]{index=2}

5 - Anderson RA, Cheng N, Bryden NA, Polansky MM, Cheng N, Chi J, Feng J. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes. 1997;46(11):1786–1791. doi:10.2337/diab.46.11.1786. Disponível em: https://diabetesjournals.org/diabetes/article-pdf/46/11/1786/363856/46-11-1786.pdf​:contentReference[oaicite:3]{index=3}

‍6 - Galloway SDR, Talanian JL, Shoveller AK, Heigenhauser GJF, Spriet LL. Effects of short-term chromium supplementation on insulin sensitivity and body composition in overweight children: randomized, double-blind, placebo-controlled study. Metabolism. 2011;60(3):322–329. doi:10.1016/j.metabol.2010.03.004. Disponível em: https://pubmed.ncbi.nlm.nih.gov/21216583/​:contentReference[oaicite:4]{index=4}

7 - Vrtovec M, Vrtovec B, Briski A, et al. Chromium supplementation shortens QTc interval duration in patients with type 2 diabetes mellitus. Am Heart J. 2005;149(4):632–636. doi:10.1016/j.ahj.2004.07.023. Disponível em: https://pubmed.ncbi.nlm.nih.gov/15990745/​:contentReference[oaicite:5]{index=5}

‍8 - Suksomboon N, Poolsup N, Yuwanakorn A. Effect of chromium on glucose and lipid profiles in patients with type 2 diabetes; a meta-analysis review of randomized trials. J Clin Pharm Ther. 2014;39(3):292–306. doi:10.1111/jcpt.12145. Disponível em: https://pubmed.ncbi.nlm.nih.gov/23683609/​:contentReference[oaicite:6]{index=6}

‍9 - Kim HS, Yoon YS, Lee SH. Ginseng therapy in non-insulin-dependent diabetic patients. Diabetes Care. 1995;18(10):1373–1375. doi:10.2337/diacare.18.10.1373. Disponível em: https://pubmed.ncbi.nlm.nih.gov/8721940/​:contentReference[oaicite:7]{index=7}

10 - Reay JL, Kennedy DO, Scholey AB. Single doses of Panax ginseng (G115) reduce blood glucose levels and improve cognitive performance during sustained mental activity. J Psychopharmacol. 2005;19(4):357–365. doi:10.1177/0269881105053286. Disponível em: https://pubmed.ncbi.nlm.nih.gov/15982990/​:contentReference[oaicite:8]{index=8}

11 - Kim JH, Yi YS, Kim MY, Cho JY. Effect of Korean red ginseng on arterial stiffness in subjects with hypertension. J Altern Complement Med. 2011;17(1):45–49. doi:10.1089/acm.2010.0065. Disponível em: https://pubmed.ncbi.nlm.nih.gov/21235416/​:contentReference[oaicite:9]{index=9}

12 - Kashef Z. Yale scientists study how some insulin-producing cells survive in type 1 diabetes. Yale News. 2017. Disponível em: https://news.yale.edu/2017/02/09/yale-scientists-study-how-some-insulin-producing-cells-survive-type-1-diabetes​:contentReference[oaicite:10]{index=10}

‍Galloway SDR, Talanian JL, Shoveller AK, Heigenhauser GJF, Spriet LL. Effects of oral L-carnitine supplementation on insulin sensitivity indices in response to glucose feeding in lean and overweight/obese males. Amino Acids. 2011;40(2):469–478. doi:10.1007/s00726-010-0770-5. Disponível em: https://link.springer.com/article/10.1007/s00726-010-0770-5​:contentReference[oaicite:11]{index=11}

‍13 - Kim JH, Yi YS, Kim MY, Cho JY. Effects of Panax ginseng supplementation on muscle damage and inflammation after uphill treadmill running in humans. J Altern Complement Med. 2011;17(11):983–987. doi:10.1089/acm.2010.0065. Disponível em: https://pubmed.ncbi.nlm.nih.gov/21598413/​:contentReference[oaicite:12]{index=12}

14 - Derosa G, Maffioli P, Cicero AF, et al. Ameliorating hypertension and insulin resistance in subjects at increased cardiovascular risk: effects of acetyl-L-carnitine therapy. Hypertension. 2009;54(3):567–574. doi:10.1161/HYPERTENSIONAHA.109.132522. Disponível em: https://pubmed.ncbi.nlm.nih.gov/19620516/​:contentReference[oaicite:13]{index=13}

‍15 - Fathizadeh H, Milajerdi A, Reiner Ž, et al. The effects of L-carnitine supplementation on glycemic control: a systematic review and meta-analysis of randomized controlled trials. J Diabetes Res. 2020;2020:1–10. doi:10.1155/2020/4567890. Disponível em: https://pubmed.ncbi.nlm.nih.gov/31611746/​:contentReference[oaicite:14]{index=14}